Stratus Therapeutics
Cambridge
About Stratus Therapeutics
Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases. It seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Its platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $184.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2025)
- Website: stratustx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/stratus-therapeutics-54165 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.